Claire Leurent

Claire Leurent is a seasoned professional in the biotech and healthcare investment sector with a diverse background in venture capital and drug development. She currently serves as a Managing Director at AbbVie Ventures, the corporate venturing arm of AbbVie.1

Career Highlights

Venture Capital Experience::

• Managing Director at AbbVie Ventures (Current position)1
• Principal at Johnson & Johnson Innovation – JJDC (2019-2023)1
• Managing Director at Samsung Venture Investment (2018-2019)67
• Bio Sector Investment Director at Samsung Ventures America (2017-2019)57

Pharmaceutical Industry Experience::

• 14 years in drug development at companies including Forenap Pharma, Wyeth Pharmaceuticals, and Pfizer Inc.4
• Roles in various stages of drug development, from discovery to registration studies2

Education and Expertise

• PhD in Biology3
• MBA from MIT Sloan (obtained in June 2016)2
• Expertise in areas such as neurosciences, oncology, infectious diseases, vaccines, cardiovascular and renal diseases, ophthalmology, immunology, and inflammation2

Investment Focus

Claire Leurent specializes in strategic investments in biotech and healthcare, with experience in:

• Deploying capital in Life Science, Health Economics, and Connected Health sectors2
• Investing across various stages, from Seed to PIPE/SPAC2
• Focus on transformative technologies and business models in healthcare2

Throughout her career, Claire Leurent has demonstrated a passion for science and people, leveraging her operational experience in drug development to make strategic investment decisions in the biotech and healthcare sectors.